Neonatology in the emerging countries: The strategies and health-economics challenges related to prevention of neonatal and infant infections

Early Human Development

Volumn 88, Issue SUPPL.2, 2012, Pages

  Vain, N E ^a,b,c   Farina D ^c,d   Vazquez L N ^a  

^a Sanatorio de la Trinidad   (Argentina)

^b Fundasamin ^*  (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPHOTERICIN B; AMPICILLIN; CEPHALOSPORIN; CHLORHEXIDINE; FLUCONAZOLE; GENTAMICIN; PALIVIZUMAB; VACCINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTIFICIAL MILK; ATTITUDE TO HEALTH; BIRTH WEIGHT; BLOOD CULTURE; BOVINE RESPIRATORY SYNCYTIAL VIRUS INFECTION; BREAST FEEDING; BREAST MILK; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DISEASE COURSE; DISEASE TRANSMISSION; DISINFECTION; ESCHERICHIA COLI; FOLLOW UP; GESTATIONAL AGE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAND WASHING; HEALTH BEHAVIOR; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HEALTH ECONOMICS; HEALTH EDUCATION; HEALTH PROGRAM; HEALTH PROMOTION; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; IMMUNOCOMPROMISED PATIENT; INFANT MORTALITY; INFECTION PREVENTION; INFECTION RISK; INTESTINE FLORA; INTRAVENOUS CATHETER; INVASIVE CANDIDIASIS; KLEBSIELLA; LIVE BIRTH; LUNG DYSPLASIA; MASTITIS; MEDICAL EDUCATION; MILK PRODUCTION; NECROTIZING ENTEROCOLITIS; NEONATOLOGY; NEWBORN CARE; NEWBORN INFECTION; NEWBORN INTENSIVE CARE; NEWBORN SEPSIS; PNEUMONIA; PREMATURITY; PROTECTIVE CLOTHING; REVIEW; SEPSIS; SKIN CARE; SOCIOECONOMICS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SURVIVAL RATE; TREATMENT INDICATION;

ANTI-BACTERIAL AGENTS; BREAST FEEDING; DEVELOPING COUNTRIES; DRUG UTILIZATION; HAND DISINFECTION; HEALTH MANPOWER; HEALTH PERSONNEL; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INFECTION; INFECTION CONTROL; INTENSIVE CARE UNITS, NEONATAL; NEONATOLOGY; RESPIRATORY TRACT INFECTIONS; RISK FACTORS;

EID: 84861469326     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/S0378-3782(12)70016-6     Document Type: Review

References (74)

1. Borghesi A, Stronati M Strategies for the prevention of hospital-acquired infections in the neonatal intensive care unit. J Hosp Infect 2008, 68(4):293-300.
2. Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010, 126(3):443-456.
3. Farina D, Rodriguez SP, Bauer G, Novali L, Bouzas L, Gonzalez H, et al. Respiratory syncytial virus prophylaxis: cost-effective analysis in Argentina. Pediatr Infect Dis J 2002, 21(4):287-291.
4. D'Apremont I, Tapia JL, Quezada M, Gederlini A, García Zattera MJ, Marshall G, et al. Neocosur: Informe Anual 2008. Rev Hosp Mat Inf Ramón Sardá 2008, 27(4):166-178.
5. Cimiotti JP, Haas J, Saiman L, Larson EL Impact of staffing on bloodstream infections in the neonatal intensive care unit. Arch Pediatr Adolesc Med 2006, 160(8):832-836.
6. Hugonnet S, Uckay I, Pittet D Staffing level: a determinant of late-onset ventilator-associated pneumonia. Crit Care 2007, 11(4):R80.
7. Manojlovich M, Sidani S, Covell CL, Antonakos CL Nurse dose: linking staffing variables to adverse patient outcomes. Nurs Res 2011, 60(4):214-220.
8. (last accessed January 10, 2012). http://edant.clarin.com/diario/2008/09/14/sociedad/s-01759962.htm.
9. (last accessed January 10, 2012). http://www.unicef.org/argentina/spanish/GUIA_MSCF.pdf.
10. (last accessed January 10, 2012). http://www.fundasamin.org.ar.
11. Chirico G, Marzollo R, Cortinovis S, Fonte C, Gasparoni A Antiinfective properties of human milk. J Nutr 2008, 138(9):1801S-1806S.
12. Edmond KM, Kirkwood BR, Amenga-Etego S, Owusu-Agyei S, Hurt LS Effect of early infant feeding practices on infection-specific neonatal mortality: an investigation of the causal links with observational data from rural Ghana. Am J Clin Nutr 2007, 86(4):1126-1131.
13. Larguia AM, Urman J, Stoliar OA, Ceriani JM, O'Donnell A, Buscaglia JC, et al. Fresh human colostrum for the prevention of E. coli diarrhea - a clinical experience. J Trop Pediatr Environ Child Health 1977, 23(6):289-290.
14. Sisk PM, Lovelady CA, Dillard RG, Gruber KJ, O'Shea TM Early human milk feeding is associated with a lower risk of necrotizing enterocolitis in very low birth weight infants. J Perinatol 2007, 27(7):428-433.
15. Meinzen-Derr J, Morrow AL, Hornung RW, Donovan EF, Dietrich KN, Succop PA Epidemiology of necrotizing enterocolitis temporal clustering in two neonatology practices. J Pediatr 2009, 154(5):656-661.
16. Meinzen-Derr J, Poindexter B, Wrage L, Morrow AL, Stoll B, Donovan EF Role of human milk in extremely low birth weight infants' risk of necrotizing enterocolitis or death. J Perinatol 2009, 29(1):57-62.
17. Sullivan S, Schanler RJ, Kim JH, Patel AL, Trawoger R, Kiechl-Kohlendorfer U, et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr 2010, 156(4):562. 7.e1.
18. Ronnestad A, Abrahamsen TG, Medbo S, Reigstad H, Lossius K, Kaaresen PI, et al. Late-onset septicemia in a Norwegian national cohort of extremely premature infants receiving very early full human milk feeding. Pediatrics 2005, 115(3):e269-e276.
19. Schanler RJ Outcomes of human milk-fed premature infants. Semin Perinatol 2011, 35(1):29-33.
20. Furman L, Minich N, Hack M Correlates of lactation in mothers of very low birth weight infants. Pediatrics 2002, 109(4):e57.
21. Charpak N, Ruiz-Pelaez JG, Charpak Y Rey-Martinez Kangaroo Mother Program: an alternative way of caring for low birth weight infants? One year mortality in a two cohort study. Pediatrics 1994, 94(6 Pt 1):804-810.
22. Whitelaw A, Heisterkamp G, Sleath K, Acolet D, Richards M Skin to skin contact for very low birthweight infants and their mothers. Arch Dis Child 1988, 63(11):1377-1381.
23. Anderson GC Skin to skin: Kangaroo Care in western Europe. Am J Nurs 1989, 89(5):662-666.
24. Conde-Agudelo A, Belizan JM, Diaz-Rossello J Kangaroo mother care to reduce morbidity and mortality in low birthweight infants. Cochrane Database Syst Rev 2011, (3). CD002771.
25. (last accessed January 4, 2012). http://www.sarda.org.ar/Institucional/Modelo_Sarda/Acciones/.
26. Sisk PM, Lovelady CA, Dillard RG, Gruber KJ Lactation counseling for mothers of very low birth weight infants: effect on maternal anxiety and infant intake of human milk. Pediatrics 2006, 117(1):e67-e75.
27. Zuppa AA, Sindico P, Orchi C, Carducci C, Cardiello V, Romagnoli C Safety and efficacy of galactogogues: substances that induce, maintain and increase breast milk production. J Pharm Pharm Sci 2010, 13(2):162-174.
28. Pinelli J, Symington A Non-nutritive sucking for promoting physiologic stability and nutrition in preterm infants. Cochrane Database Syst Rev 2005, (4). CD001071.
29. Schanler RJ Evaluation of the evidence to support current recommendations to meet the needs of premature infants: the role of human milk. Am J Clin Nutr 2007, 85(2):625S-628S.
30. Ziegler EE Meeting the nutritional needs of the low-birth-weight infant. Ann Nutr Metab 2011, 58(Suppl 1):8-18.
31. Kuschel CA, Harding JE Multicomponent fortified human milk for promoting growth in preterm infants. Cochrane Database Syst Rev 2004, (1). CD000343.
32. Boyd CA, Quigley MA, Brocklehurst P Donor breast milk versus infant formula for preterm infants: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2007, 92(3):F169-F175.
33. Quigley MA, Henderson G, Anthony MY, McGuire W Formula milk versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database Syst Rev 2007, (4). CD002971.
34. Gagneur A, Hery-Arnaud G, Croly-Labourdette S, Gremmo-Feger G, Vallet S, Sizun J, et al. Infected breast milk associated with late-onset and recurrent group B streptococcal infection in neonatal twins: a genetic analysis. Eur J Pediatr 2009, 168(9):1155-1158.
35. Sánchez J, Rodríguez P [We can and must improve hand hygiene. You decide. "Clean care is safer care"]. Enferm Infecc Microbiol Clin 2011, 29(1):1-3. In Spanish.
36. Tschudin-Sutter S, Pargger H, Widmer AF Hand hygiene in the intensive care unit. Crit Care Med 2010, 38(8 Suppl):S299-S305.
37. (last accessed January 10, 2012). http://whqlibdoc.who.int/publications/2009/9789241597906_eng.pdf.
38. Bolon M Hand hygiene. Infect Dis Clin North Am 2011, 25(1):21-43.
39. Boyce JM, Pittet D Guideline for hand hygiene in health-care settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm Rep 2002, 51(RR-16):1-45. quiz: CE1-4.
40. WHO Guidelines on Hand Hygiene in Health Care (last accessed January 10, 2012). http://www.who.int/gpsc/5may/background/5moments/en/index.html.
41. Helms B, Dorval S, Laurent PS, Winter M Improving hand hygiene compliance: a multidisciplinary approach. Am J Infect Control 2010, 38(7):572-574.
42. Pittet D Improving adherence to hand hygiene practice: a multidisciplinary approach. Emerg Infect Dis 2001, 7(2):234-240.
43. Kilbride HW, Wirtschafter DD, Powers RJ, Sheehan MB Implementation of evidence-based potentially better practices to decrease nosocomial infections. Pediatrics 2003, 111(4Pt 2):e519-e533.
44. Fanaroff AA, Korones SB, Wright LL, Verter J, Poland RL, Bauer CR, et al. Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. The National Institute of Child Health and Human Development Neonatal Research Network. Pediatr Infect Dis J 1998, 17(7):593-598.
45. Grohskopf LA, Huskins WC, Sinkowitz-Cochran RL, Levine GL, Goldmann DA, Jarvis WR, Pediatric Prevention Network Use of antimicrobial agents in United States neonatal and pediatric intensive care patients. Pediatr Infect Dis J 2005, 24(9):766-773.
46. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002, 110(2 Pt 1):285-291.
47. Sohn AH, Garrett DO, Sinkowitz-Cochran RL, Grohskopf LA, Levine GL, Stover BH, et al. Prevalence of nosocomial infections in neonatal intensive care unit patients: Results from the first national point-prevalence survey. J Pediatr 2001, 139(6):821-827.
48. Kubin CJ Antimicrobial control programs. Semin Perinatol 2002, 26(5):379-386.
49. Rowley AH, Wald ER Incubation period necessary to detect bacteremia in neonates. Pediatr Infect Dis 1986, 5(5):590-591.
50. Kaiser JR, Cassat JE, Lewno MJ Should antibiotics be discontinued at 48 hours for negative late-onset sepsis evaluations in the neonatal intensive care unit?. J Perinatol 2002, 22(6):445-447.
51. Benjamin DK, Stoll BJ, Gantz MG, Walsh MC, Sanchez PJ, Das A, et al. Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics 2010, 126(4):e865-e873.
52. Weese-Mayer DE, Fondriest DW, Brouillette RT, Shulman ST Risk factors associated with candidemia in the neonatal intensive care unit: a case-control study. Pediatr Infect Dis J 1987, 6(2):190-196.
53. Cotten CM, Taylor S, Stoll B, Goldberg RN, Hansen NI, Sanchez PJ, et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 2009, 123(1):58-66.
54. Alexander VN, Northrup V, Bizzarro MJ Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis. J Pediatr 2011, 159(3):392-397.
55. Kuppala VS, Meinzen-Derr J, Morrow AL, Schibler KR Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J Pediatr 2011, 159(5):720-725.
56. Isaacs D Unnatural selection: reducing antibiotic resistance in neonatal units. Arch Dis Child Fetal Neonatal Ed 2006, 91(1):F72-F74.
57. Patel SJ, Saiman L Antibiotic resistance in neonatal intensive care unit pathogens: mechanisms, clinical impact, and prevention including antibiotic stewardship. Clin Perinatol 2010, 37(3):547-563.
58. Isaacs D Rationing antibiotic use in neonatal units. Arch Dis Child Fetal Neonatal Ed 2000, 82(1):F1-F2.
59. de Man P, Verhoeven BA, Verbrugh HA, Vos MC, van den Anker JN An antibiotic policy to prevent emergence of resistant bacilli. Lancet 2000, 355(9208):973-978.
60. Calil R, Marba ST, von Nowakonski A, Tresoldi AT Reduction in colonization and nosocomial infection by multiresistant bacteria in a neonatal unit after institution of educational measures and restriction in the use of cephalosporins. Am J Infect Control 2001, 29(3):133-138.
61. Spritzer R, vd Kamp HJ, Dzoljic G, Sauer PJ Five years of cefotaxime use in a neonatal intensive care unit. Pediatr Infect Dis J 1990, 9(2):92-96.
62. White AC, Atmar RL, Wilson J, Cate TR, Stager CE, Greenberg SB Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis 1997, 25(2):230-239.
63. Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007, 44(2):159-177.
64. Váizquez L, Cracco L, Garcia C, Silva C, Vain NE. Epidemiological surveillance in a neonatal intensive care unit (NICU). Presented at Pediatric Academic Societies 2008 Meeting, May 2-5, 2008, Honolulu, Hawaii.
65. Vain NE, Vázquez LN Prophylactic fluconazole in preterm neonates. N Engl J Med 2007, 357(13):1348-1349.
66. Shlaes DM, Gerding DN, John JF, Craig WA, Bornstein DL, Duncan RA, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997, 25(3):584-599.
67. Talbot GH, Bradley J, Edwards JE, Gilbert D, Scheld M, Bartlett JG Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 2006, 42(5):657-668.
68. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010, 375(9725):1545-1555.
69. The IMpact-RSV Study Group Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998, 102(3 Pt 1):531-537.
70. The PREVENT Study Group Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. Pediatrics 1997, 99(1):93-99.
71. Carbonell-Estrany X, Quero J, IRIS Study Group Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons. Pediatr Infect Dis J 2001, 20(9):874-879.
72. Bauer G, Dussel V, Fariña D, Rodríguez S Infección por virus sincicial respiratorio en poblaciones vulnerables: riesgo biolóigico contra riesgo social. Arch Argent Pediatr 2005, 103(3):198-204.
73. Rodríguez SP, Fariña D, Bauer G Respiratory syncytial virus prophylaxis in a high-risk population in Argentina: a cost-effectiveness analysis. Pediatr Infect Dis J 2008, 27:660-661.
74. Bauer G, Bossi L, Santoalla M, Rodriguez S, Fariña D, Speranza AM Impact of a respiratory disease prevention program in high-risk preterm infants: a prospective, multicentric study. Arch Argent Pediatr 2009, 107(2):111-118.